
Shennapsi develops and manufactures AI-powered medical-grade wearable devices that monitor cardiac signals and metabolic markers such as uric acid, blood glucose, and cholesterol. The company combines embedded sensors, device hardware, and machine learning algorithms, including an AI-ECG diagnostic analysis system and CUMS metabolic monitoring, to generate clinical-grade readings. It operates as a B2B medical device and AI hardware provider serving hospitals, clinics, research institutions, and healthtech partners. Shennapsi focuses on end-to-end R&D and manufacturing of regulated wearables and integration with clinical workflows and research platforms.

Shennapsi develops and manufactures AI-powered medical-grade wearable devices that monitor cardiac signals and metabolic markers such as uric acid, blood glucose, and cholesterol. The company combines embedded sensors, device hardware, and machine learning algorithms, including an AI-ECG diagnostic analysis system and CUMS metabolic monitoring, to generate clinical-grade readings. It operates as a B2B medical device and AI hardware provider serving hospitals, clinics, research institutions, and healthtech partners. Shennapsi focuses on end-to-end R&D and manufacturing of regulated wearables and integration with clinical workflows and research platforms.